Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Jun 16, 2020 | etherna immunotherapies | $38.4M Series B | — | BNP Paribas Fortis Private Equity, Boehringer Ingelheim, Fund+, LSP, Novalis LifeSciences, Omega Funds, PMV, Yijing Capital |
| Jun 16, 2020 | Etherna | $38.4M Series B | — | BNP Paribas Fortis Private Equity, Boehringer Ingelheim Venture Fund, Fund+, LSP, Novalis LifeSciences, Omega Funds, PMV, Yijing Capital |